Recombinant Human FMO3 Protein，His

The study of the FMO3 (Flavin-containing monooxygenase 3) recombinant protein has gained significant attention due to its crucial role in drug metabolism and regulation of endogenous compounds. FMO3 is part of the flavin-containing monooxygenase enzyme family, which is involved in the oxidation of a wide array of substrates, including pharmaceuticals, dietary components, and environmental toxins. Variability in FMO3 activity among individuals can lead to differences in drug efficacy and toxicity, highlighting its importance in personalized medicine. Genetic polymorphisms, particularly those affecting the FMO3 gene, can influence enzyme function and have been linked to various health conditions, such as trimethylaminuria, where defective FMO3 leads to the accumulation of trimethylamine, resulting in unpleasant body odor. Furthermore, the recombinant expression of FMO3 in heterologous systems allows for in-depth studies of its enzymatic properties, substrate specificity, and interactions with other metabolic pathways. This enables researchers to better understand how FMO3 contributes to metabolic networks and can aid in the development of therapeutics that are tailored to individual metabolic profiles. Overall, the exploration of FMO3 recombinant protein serves not only to elucidate its biochemical functions but also offers potential insights into pharmacogenomics, toxicology, and the development of safer, more effective drugs.